MY ACCOUNT | NEWSLETTER |

Mastitis greatly increases the risk of teat fistula surgical repair failure a retrospective study of 92 lactating dairy cattle (1994-2019).

Clinical evidence update from Journal of the American Veterinary Medical Association


Clinical Context

Peer-reviewed veterinary literature continues to shape everyday decision-making for production animal practice, especially when new evidence clarifies diagnosis, treatment selection, monitoring, or clinical outcomes.

What the Study Evaluated

A study published in Journal of the American Veterinary Medical Association in 2026 evaluated mastitis greatly increases the risk of teat fistula surgical repair failure: a retrospective study of 92 lactating dairy cattle (1994-2019)..

Key Findings

To evaluate risk factors for the recurrence of teat fistulas following surgery and to assess the long-term outcomes of surgery for teat fistulas in lactating dairy cows. A retrospective case series was conducted on 92 lactating dairy cows that underwent surgical repair for congenital or acquired teat fistulas from 1994 to 2019 at the Veterinary Teaching Hospital of Urmia University, Iran. Acquired fistulas were further subdivided etiologically into 2 distinct categories: (1) primary chronic fistulas, defined as full-thickness teat lacerations that were not recognized promptly and healed by second intention, and (2) surgery-related fistulas,...

Why It Matters for Veterinary Professionals

For veterinary professionals, the practical value of this work lies in how the findings may support more structured clinical assessment, clearer monitoring, and more informed decisions for production animal practice.

Practical Interpretation

The results should be interpreted in the context of the study design, population, inclusion criteria, and clinical setting. Application in practice should consider patient-specific risk factors, available diagnostics, local standards of care, and clinician judgment.

Clinical Takeaway

Overall, the study adds useful evidence for clinicians seeking to align daily practice with current veterinary research while maintaining a balanced, case-by-case approach.

Read the full article here.

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

The Lundquist Institute Launches the Nation's First Adult Exercise Medicine Fellowship

Like0
Dislike0

Efficacy of high-dose carvedilol treatment for cats with stage B1 obstructive hypertrophic cardiomyopathy.

Like0
Dislike0

A retrospective (2020-2025), multicenter study of myxomatous mitral valve disease in Chihuahuas from Italy, Sweden, and the United States of America.

Like0
Dislike0

WSU welcomes new house officers

Like0
Dislike0

Exubrion Therapeutics Promotes Gregory Taglialatela to Chief Commercial Officer

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2026 - All Rights Reserved
ISSN 2768-198X

Top